Medtronic wins FDA approval for Sprint Quattro Secure defibrillation lead

The Medtronic Sprint Quattro Secure S lead is designed with an 8.6 French diameter lead body. A thin wire inserted into the chambers of the heart through blood vessels, the lead is said to be compatible with any Medtronic implantable cardioverter-defibrillator or cardiac resynchronization therapy-defibrillator, which are stopwatch-sized devices that administer electrical shocks or painless pacing therapy to stop dangerous ventricular arrhythmias.

This new defibrillation lead is an addition to the Sprint Quattro family that provides an option for physicians who prefer a specific type of lead for patients with unique anatomies and is designed to help reduce tip pressure.

In conjunction with this introduction, Medtronic is extending its defibrillation lead warranty to a lifetime limited warranty, which covers all defibrillation leads implanted in the US on or after December 1, 2008. Under the lifetime warranty, Medtronic will provide a replacement lead at no charge if the lead does not perform according to specification and meets other specified warranty criteria. It also will reimburse patients for certain unreimbursed medical expenses in the amount specified in the warranty.

Pat Mackin, president of cardiac rhythm disease management business and senior vice president at Medtronic, said: The Sprint Quattro family of defibrillation leads is highly respected in the cardiac community. We are pleased the FDA has approved this single coil option, which gives physicians another choice in order to deliver the appropriate treatment to each individual patient.